SUZANNE FUQUA to Molecular Targeted Therapy
This is a "connection" page, showing publications SUZANNE FUQUA has written about Molecular Targeted Therapy.
Connection Strength
1.717
-
ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges. Br J Cancer. 2022 02; 126(2):174-186.
Score: 0.625
-
The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer. Horm Cancer. 2018 08; 9(4):215-228.
Score: 0.493
-
Targeted therapy for breast cancer and molecular mechanisms of resistance to treatment. Curr Opin Pharmacol. 2016 12; 31:97-103.
Score: 0.446
-
Metastasis: complexity thwarts precision targeting. Br J Cancer. 2021 10; 125(8):1033-1035.
Score: 0.153